middle.news
MedAdvisor Scores Premium Offer for ANZ Business in Strategic Play
8:38am on Wednesday 7th of May, 2025 AEST
•
Healthcare
Read Story
MedAdvisor Scores Premium Offer for ANZ Business in Strategic Play
8:38am on Wednesday 7th of May, 2025 AEST
Key Points
Non-binding Letter of Intent received from multinational software firm
Offer values ANZ business above current MedAdvisor share price
ANZ division posts record revenue of A$2.9 million in April 2025
Due diligence exclusivity period set for 5 to 7 weeks
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MDR
OPEN ARTICLE